Compare Palo Alto Networks Inc (PANW) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Palo Alto Networks Inc vs TransMedics Group Inc — how do they compare? Palo Alto Networks Inc trades at $335.85 (market cap $273.11B), while TransMedics Group Inc trades at $86.4 (market cap $3.00B). The key difference: Palo Alto Networks Inc is far larger — about 91× TransMedics Group Inc's market cap, and Palo Alto Networks Inc is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| PANW | TMDX | |
|---|---|---|
Market Cap | $273.11B | $3.00B |
Sector | Technology | Technology |
52-Week High | $396.00 | $150.42 |
52-Week Low | $141.67 | $61.99 |
Enterprise Value | $272.07B | $3.39B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Palo Alto Networks (PANW) trades at $336.98, up 1.12% with a bearish technical signal but strong fundamentals. Revenue grew to $9.22B in 2025, with EPS beats in recent quarters. The stock faces high valuation multiples (P/E 293.03) and mixed sentiment amid AI-driven growth and recent price volatility.
Outlook: Growth is supported by AI security demand and platformization strategy, but risks include premium valuation and competitive pressures. Analyst consensus is bullish with a $410.48 price target, though technical indicators suggest near-term caution.
TransMedics Group (TMDX) trades at $88.27, down 1.9% on the day, with a bullish technical signal from moving averages but mixed earnings results. The company reported strong revenue growth to $605.49M in 2025, with a net income margin of 22.69%, though profitability is expected to moderate in 2026. Recent news highlights ongoing legal investigations into fiduciary duties alongside positive coverage of growth initiatives in kidney transplantation and European expansion.
The stock presents a growth opportunity with analyst consensus pointing to a $99.57 price target, but risks include margin pressure from heavy investments and legal uncertainties. Earnings misses in recent quarters and a projected decline in net income for 2026 warrant caution, though institutional interest remains with a bullish rating from 69% of analysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Palo Alto Networks Inc
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
